Sleep Apnea Devices Market Report 2015 - Analysis & Global Forecasts to 2020: Market Expected to Reach $5.3 Billion
DUBLIN, Sept. 15, 2015 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/bcjmt9/sleep_apnea) has announced the addition of the "Sleep Apnea Devices Market by Product, Diagnostic, Therapeutic [CPAP, APAP, BPAP, Masks , Oral Appliances (Mandibular Advancement Device)], End User (Home Care Settings, Hospitals) - Analysis & Global Forecasts to 2020" report to their offering.
The sleep apnea devices market is expected to reach $5.3 Billion in 2020 from $3.8 Billion in 2015, at a CAGR of 7.2%.
The global sleep apnea devices market is segmented on the basis of types, end user, and region. By type, the market is categorized into diagnostic and therapeutic devices. In 2015, the therapeutic sleep apnea devices segment is estimated to account for the largest market share and grow at the fastest rate.
Based on end user, the sleep apnea devices market is divided into home care and sleep laboratories and hospitals. In 2015, the home care segment is expected to account for the largest share and grow at the fastest rate . This can be attributed to the patient preference for these home-use devices (comfort) . In addition, the growing trend of using home sleep testing devices instead of visiting sleep laboratories is expected to boost the growth of the home care segment.
The market is dominated by North America, followed by Europe, Asia- Pacific, and the Rest of the World (RoW). Europe is expected to grow at the fastest rate . The increase in awareness of sleep apnea in the region, coupled with the improving reimbursement scenario in many countries, is expected to enable Europe to be the fastest -growing region during the forecast period . Furthermore, government and trade association interventions, to address untreated sleep apnea, will act as a growth driver in the region.
Some major players in the global sleep apnea devices market include ResMed, Inc. (U.S.), Philips Healthcare (Netherlands), Fisher & Paykel Healthcare Ltd. (New Zealand), Compumedics Ltd. (Australia), SomnoMed (Australia), and Whole You, Inc. (U.S.).
For more information visit http://www.researchandmarkets.com/research/bcjmt9/sleep_apnea
Media Contact:
Laura Wood, +353-1-481-1716, press@researchandmarkets.net
Share this article